1. Home
  2. CYTK
  3. CYTK News

Latest Cytokinetics Incorporated (CYTK) News on July 26, 2024

Cytokinetics to Announce Second Quarter Results on August 8, 2024
CYTK

GlobeNewswire

a day ago

Cytokinetics to Announce Second Quarter Results on August 8, 2024

Cytokinetics (CYTK) Expected to Beat Earnings Estimates: Should You Buy?
CYTK

Zacks

a day ago

Cytokinetics (CYTK) Expected to Beat Earnings Estimates: Should You Buy?

CYTK

Argus Research

3 days ago

CYTK: Raising target price to $46.00

Insider Sale: EVP Research & Development Fady Malik Sells Shares of Cytokinetics Inc (CYTK)
CYTK

GuruFocus.com

3 days ago

Insider Sale: EVP Research & Development Fady Malik Sells Shares of Cytokinetics Inc (CYTK)

CYTK

MT Newswires

3 days ago

Cytokinetics Insider Sold Shares Worth $416,246, According to a Recent SEC Filing

CYTK

Argus Research

10 days ago

CYTK: Raising target price to $45.00

Cytokinetics Announces Seven Upcoming Presentations at the European Society of Cardiology Congress 2024
CYTK

GlobeNewswire

11 days ago

Cytokinetics Announces Seven Upcoming Presentations at the European Society of Cardiology Congress 2024

Cytokinetics' Wild Ride: CEO Defends Deal That Rattled Wall Street
CYTK

Investor's Business Daily

15 days ago

Cytokinetics' Wild Ride: CEO Defends Deal That Rattled Wall Street

Cytokinetics' Wild Ride: Can Investors Forgive The Royalty Pharma Deal?
CYTK

Investor's Business Daily

15 days ago

Cytokinetics' Wild Ride: Can Investors Forgive The Royalty Pharma Deal?

Insider Sale: EVP Research & Development Fady Malik Sells Shares of Cytokinetics Inc (CYTK)
CYTK

GuruFocus.com

17 days ago

Insider Sale: EVP Research & Development Fady Malik Sells Shares of Cytokinetics Inc (CYTK)

CYTK

Argus Research

17 days ago

CYTK: Lowering target price to $44.00

Cytokinetics Announces Inducement Grants Under Nasdaq Listing Rule 5635(C)(4)
CYTK

GlobeNewswire

23 days ago

Cytokinetics Announces Inducement Grants Under Nasdaq Listing Rule 5635(C)(4)

CYTK

Argus Research

24 days ago

CYTK: Rating decreased to a SELL

Insider Sale: Director B Parshall Sells 5,000 Shares of Cytokinetics Inc (CYTK)
CYTK

GuruFocus.com

25 days ago

Insider Sale: Director B Parshall Sells 5,000 Shares of Cytokinetics Inc (CYTK)

CYTK

MT Newswires

a month ago

JPMorgan Cuts Price Target on Cytokinetics to $65 From $77, Maintains Overweight Rating

Insider Selling: Director B Parshall Sells Shares of Cytokinetics Inc (CYTK)
CYTK

GuruFocus.com

a month ago

Insider Selling: Director B Parshall Sells Shares of Cytokinetics Inc (CYTK)

CYTK

MT Newswires

a month ago

Cytokinetics Insider Sold Shares Worth $262,750, According to a Recent SEC Filing

CYTK

MT Newswires

a month ago

Cytokinetics Insider Sold Shares Worth $1,183,391, According to a Recent SEC Filing

Cytokinetics Announces Initiation of Phase 1 Study of Aficamten in Healthy Japanese Participants
CYTK

GlobeNewswire

a month ago

Cytokinetics Announces Initiation of Phase 1 Study of Aficamten in Healthy Japanese Participants

Insider Sale at Cytokinetics Inc (CYTK) by EVP of Research & Development
CYTK

GuruFocus.com

a month ago

Insider Sale at Cytokinetics Inc (CYTK) by EVP of Research & Development

CYTK

MT Newswires

a month ago

Cytokinetics Insider Sold Shares Worth $413,106, According to a Recent SEC Filing

Insider Sale: Director Muna Bhanji Sells Shares of Cytokinetics Inc (CYTK)
CYTK

GuruFocus.com

2 months ago

Insider Sale: Director Muna Bhanji Sells Shares of Cytokinetics Inc (CYTK)

Lotto 6/49 - $64 million up for grabs in the next draw!
CYTK

CNW Group

2 months ago

Lotto 6/49 - $64 million up for grabs in the next draw!

Returns On Capital At B&S Group (AMS:BSGR) Paint A Concerning Picture
CYTK

Simply Wall St.

2 months ago

Returns On Capital At B&S Group (AMS:BSGR) Paint A Concerning Picture

Seoul says it will resume loudspeaker propaganda against North
CYTK

AFP

2 months ago

Seoul says it will resume loudspeaker propaganda against North

It Might Not Be A Great Idea To Buy PATRIZIA SE (ETR:PAT) For Its Next Dividend
CYTK

Simply Wall St.

2 months ago

It Might Not Be A Great Idea To Buy PATRIZIA SE (ETR:PAT) For Its Next Dividend

OUTsurance Group Insiders Placed Bullish Bets Worth R25.5m
CYTK

Simply Wall St.

2 months ago

OUTsurance Group Insiders Placed Bullish Bets Worth R25.5m

Fed Meeting, Inflation Report, Apple’s WWDC, Broadcom Earnings, and More to Watch This Week
CYTK

Barrons.com

2 months ago

Fed Meeting, Inflation Report, Apple’s WWDC, Broadcom Earnings, and More to Watch This Week

Just Three Days Till BREMER LAGERHAUS-GESELLSCHAFT -Aktiengesellschaft von 1877- (FRA:BLH) Will Be Trading Ex-Dividend
CYTK

Simply Wall St.

2 months ago

Just Three Days Till BREMER LAGERHAUS-GESELLSCHAFT -Aktiengesellschaft von 1877- (FRA:BLH) Will Be Trading Ex-Dividend

An Intrinsic Calculation For ORIOR AG (VTX:ORON) Suggests It's 35% Undervalued
CYTK

Simply Wall St.

2 months ago

An Intrinsic Calculation For ORIOR AG (VTX:ORON) Suggests It's 35% Undervalued

CYTK

MT Newswires

2 months ago

Cytokinetics Insider Sold Shares Worth $1,099,125, According to a Recent SEC Filing

CYTK

MT Newswires

2 months ago

Sector Update: Health Care Stocks Advance Late Afternoon

CYTK

MT Newswires

2 months ago

Sector Update: Health Care Stocks Rise Wednesday Afternoon

CYTK

MT Newswires

2 months ago

Cytokinetics Says Third Party Dropped Takeover Bid Despite Negotiations; Shares Rise

Lilly details MASH data for tirzepatide; Cytokinetics comments on past sale talks
CYTK

BioPharma Dive

2 months ago

Lilly details MASH data for tirzepatide; Cytokinetics comments on past sale talks

Insider Sale: Director B Parshall Sells Shares of Cytokinetics Inc (CYTK)
CYTK

GuruFocus.com

2 months ago

Insider Sale: Director B Parshall Sells Shares of Cytokinetics Inc (CYTK)

Cytokinetics Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
CYTK

GlobeNewswire

2 months ago

Cytokinetics Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)

CYTK

MT Newswires

2 months ago

B. Riley Cuts Price Target on Cytokinetics to $92 From $122, Maintains Buy Rating

Insider Sale: VP, Chief Accounting Officer Robert Wong Sells Shares of Cytokinetics Inc (CYTK)
CYTK

GuruFocus.com

2 months ago

Insider Sale: VP, Chief Accounting Officer Robert Wong Sells Shares of Cytokinetics Inc (CYTK)

CYTK

MT Newswires

2 months ago

Cytokinetics Insider Sold Shares Worth $635,978, According to a Recent SEC Filing

Cytokinetics to Participate in June Investor Conferences
CYTK

GlobeNewswire

2 months ago

Cytokinetics to Participate in June Investor Conferences

CYTK

MT Newswires

2 months ago

Truist Securities Lowers Price Target on Cytokinetics to $70 From $86, Maintains Buy Rating

CYTK

MT Newswires

2 months ago

Cytokinetics Closes $500 Million Stock Offering

Cytokinetics Announces Closing of Public Offering of Common Stock
CYTK

GlobeNewswire

2 months ago

Cytokinetics Announces Closing of Public Offering of Common Stock

CYTK

MT Newswires

2 months ago

JMP Securities Adjusts Cytokinetics Price Target to $78 From $106, Maintains Market Outperform Rating

Is Cytokinetics, Incorporated (NASDAQ:CYTK) the Best Mid-Cap Healthcare Stock To Buy Now?
CYTK

Insider Monkey

2 months ago

Is Cytokinetics, Incorporated (NASDAQ:CYTK) the Best Mid-Cap Healthcare Stock To Buy Now?

Why Cytokinetics (CYTK) Stock Price Was Down 17% on Thursday
CYTK

Zacks

2 months ago

Why Cytokinetics (CYTK) Stock Price Was Down 17% on Thursday

CYTK

MT Newswires

2 months ago

Raymond James Adjusts Price Target on Cytokinetics to $70 From $92, Maintains Outperform Rating

CYTK

MT Newswires

2 months ago

Sector Update: Health Care Stocks Flat to Lower Premarket Thursday

CYTK

MT Newswires

2 months ago

Needham Adjusts Price Target on Cytokinetics to $72 From $108, Maintains Buy Rating

CYTK

MT Newswires

2 months ago

Top Premarket Decliners

Cytokinetics secures up to $575M in royalty deal, frustrating investors
CYTK

BioPharma Dive

2 months ago

Cytokinetics secures up to $575M in royalty deal, frustrating investors

CYTK

MT Newswires

2 months ago

Cytokinetics Prices $500 Million Common Stock Offering

Cytokinetics Announces Pricing of Public Offering of Common Stock
CYTK

GlobeNewswire

2 months ago

Cytokinetics Announces Pricing of Public Offering of Common Stock

CYTK

MT Newswires

2 months ago

Cytokinetics, Royalty Pharma Unveil up to $575 Million Funding to Advance Research Pipeline

CYTK

MT Newswires

2 months ago

Cytokinetics Plans $500 Million Common Stock Offering -- Shares Drop After Hours

Royalty Pharma and Cytokinetics Announce Expanded Strategic Funding Collaboration Totaling Up to $575 Million to Support Commercial Launch of Aficamten and to Advance R&D Pipeline
CYTK

GlobeNewswire

2 months ago

Royalty Pharma and Cytokinetics Announce Expanded Strategic Funding Collaboration Totaling Up to $575 Million to Support Commercial Launch of Aficamten and to Advance R&D Pipeline

Cytokinetics Announces Proposed Public Offering of Common Stock
CYTK

GlobeNewswire

2 months ago

Cytokinetics Announces Proposed Public Offering of Common Stock

Cytokinetics and Royalty Pharma Announce Expanded Strategic Funding Collaboration Totaling Up to $575 Million to Support Commercial Launch of Aficamten and to Advance R&D Pipeline
CYTK

GlobeNewswire

2 months ago

Cytokinetics and Royalty Pharma Announce Expanded Strategic Funding Collaboration Totaling Up to $575 Million to Support Commercial Launch of Aficamten and to Advance R&D Pipeline

Cytokinetics Hosts Muscle Biology-Focused Research Symposium: Contemporary Landscapes in Muscle Biology
CYTK

GlobeNewswire

2 months ago

Cytokinetics Hosts Muscle Biology-Focused Research Symposium: Contemporary Landscapes in Muscle Biology

Cytokinetics Announces Five Presentations Related to Aficamten at the European Society of Cardiology Congress 2024
CYTK

GlobeNewswire

2 months ago

Cytokinetics Announces Five Presentations Related to Aficamten at the European Society of Cardiology Congress 2024

Cytokinetics Reverses Higher On 'Pristine' Results For Bristol Myers-Rivaling Heart Drug
CYTK

Investor's Business Daily

2 months ago

Cytokinetics Reverses Higher On 'Pristine' Results For Bristol Myers-Rivaling Heart Drug

Health Care Roundup: Market Talk
CYTK

The Wall Street Journal

2 months ago

Health Care Roundup: Market Talk

Cytokinetics Slumps Despite 'Pristine' Results For Bristol Myers-Rivaling Heart Drug
CYTK

Investor's Business Daily

2 months ago

Cytokinetics Slumps Despite 'Pristine' Results For Bristol Myers-Rivaling Heart Drug

Cytokinetics Announces Additional Results From SEQUOIA-HCM Presented in Late Breaking Clinical Trial Session at the European Society of Cardiology Heart Failure 2024 Congress
CYTK

GlobeNewswire

2 months ago

Cytokinetics Announces Additional Results From SEQUOIA-HCM Presented in Late Breaking Clinical Trial Session at the European Society of Cardiology Heart Failure 2024 Congress

Cytokinetics Announces Primary Results From SEQUOIA-HCM Presented in Late Breaking Clinical Trial Session at the European Society of Cardiology Heart Failure 2024 Congress and Published in the New England Journal of Medicine
CYTK

GlobeNewswire

2 months ago

Cytokinetics Announces Primary Results From SEQUOIA-HCM Presented in Late Breaking Clinical Trial Session at the European Society of Cardiology Heart Failure 2024 Congress and Published in the New England Journal of Medicine

Cytokinetics Inc (CYTK) Reports Q1 2024 Earnings: Widening Losses Amid Expansive Clinical Trials
CYTK

GuruFocus.com

3 months ago

Cytokinetics Inc (CYTK) Reports Q1 2024 Earnings: Widening Losses Amid Expansive Clinical Trials

Cytokinetics First Quarter 2024 Earnings: Misses Expectations
CYTK

Simply Wall St.

3 months ago

Cytokinetics First Quarter 2024 Earnings: Misses Expectations

CYTK

MT Newswires

3 months ago

Oppenheimer Adjusts Cytokinetics Price Target to $106 From $107, Maintains Outperform Rating

Cytokinetics, Incorporated (NASDAQ:CYTK) Q1 2024 Earnings Call Transcript
CYTK

Insider Monkey

3 months ago

Cytokinetics, Incorporated (NASDAQ:CYTK) Q1 2024 Earnings Call Transcript

CYTK

GuruFocus.com

3 months ago

Cytokinetics Inc (CYTK) Q1 2024 Earnings Call Transcript Highlights: Navigating Through ...

CYTK

MT Newswires

3 months ago

Cytokinetics Q1 Net Loss Narrows, Revenue Declines

Cytokinetics (CYTK) Reports Q1 Loss, Lags Revenue Estimates
CYTK

Zacks

3 months ago

Cytokinetics (CYTK) Reports Q1 Loss, Lags Revenue Estimates

CYTK

Associated Press Finance

3 months ago

Cytokinetics: Q1 Earnings Snapshot

Cytokinetics Reports First Quarter 2024 Financial Results
CYTK

GlobeNewswire

3 months ago

Cytokinetics Reports First Quarter 2024 Financial Results

Cytokinetics Announces Topline Data From Phase 1 Clinical Study of CK-4021586
CYTK

GlobeNewswire

3 months ago

Cytokinetics Announces Topline Data From Phase 1 Clinical Study of CK-4021586

Cytokinetics Announces Start of CEDAR-HCM, a Clinical Trial of Aficamten in a Pediatric Population With Symptomatic Obstructive Hypertrophic Cardiomyopathy
CYTK

GlobeNewswire

3 months ago

Cytokinetics Announces Start of CEDAR-HCM, a Clinical Trial of Aficamten in a Pediatric Population With Symptomatic Obstructive Hypertrophic Cardiomyopathy

Insider Sale at Cytokinetics Inc (CYTK): EVP Research & Development Fady Malik Sells Shares
CYTK

GuruFocus.com

3 months ago

Insider Sale at Cytokinetics Inc (CYTK): EVP Research & Development Fady Malik Sells Shares

CYTK

MT Newswires

3 months ago

Cytokinetics Insider Sold Shares Worth $1,012,265, According to a Recent SEC Filing

Cytokinetics to Hold Annual Meeting of Stockholders
CYTK

GlobeNewswire

3 months ago

Cytokinetics to Hold Annual Meeting of Stockholders

Cytokinetics Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
CYTK

GlobeNewswire

3 months ago

Cytokinetics Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)

Cytokinetics (CYTK) May Report Negative Earnings: Know the Trend Ahead of Next Week's Release
CYTK

Zacks

3 months ago

Cytokinetics (CYTK) May Report Negative Earnings: Know the Trend Ahead of Next Week's Release

Cytokinetics to Host Investor Event and Conference Call to Discuss the Primary Results From SEQUOIA-HCM at the European Society of Cardiology Heart Failure 2024 Congress
CYTK

GlobeNewswire

3 months ago

Cytokinetics to Host Investor Event and Conference Call to Discuss the Primary Results From SEQUOIA-HCM at the European Society of Cardiology Heart Failure 2024 Congress

CYTK

MT Newswires

3 months ago

Cytokinetics Appoints Sung Lee as CFO

Cytokinetics to Announce First Quarter Results on May 8, 2024
CYTK

GlobeNewswire

3 months ago

Cytokinetics to Announce First Quarter Results on May 8, 2024

CYTK

Argus Research

3 months ago

CYTK: Lowering target price to $69.00

This weight-loss ETF has performed well in its first five months. How does it compare with cheaper alternatives?
CYTK

MarketWatch

4 months ago

This weight-loss ETF has performed well in its first five months. How does it compare with cheaper alternatives?

Cytokinetics Announces Three Late Breaking Clinical Trial Presentations Relating to SEQUOIA-HCM at the European Society of Cardiology Heart Failure 2024 Congress
CYTK

GlobeNewswire

4 months ago

Cytokinetics Announces Three Late Breaking Clinical Trial Presentations Relating to SEQUOIA-HCM at the European Society of Cardiology Heart Failure 2024 Congress

EVP Research & Development Fady Malik Sells Shares of Cytokinetics Inc (CYTK)
CYTK

GuruFocus.com

4 months ago

EVP Research & Development Fady Malik Sells Shares of Cytokinetics Inc (CYTK)

Cytokinetics Presents Additional 48-Week Data From FOREST-HCM, the Open Label Extension Clinical Study of Aficamten, at The American College of Cardiology 73ʳᵈ Annual Scientific Session
CYTK

GlobeNewswire

4 months ago

Cytokinetics Presents Additional 48-Week Data From FOREST-HCM, the Open Label Extension Clinical Study of Aficamten, at The American College of Cardiology 73ʳᵈ Annual Scientific Session

Cytokinetics Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
CYTK

GlobeNewswire

4 months ago

Cytokinetics Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)

Cytokinetics to Participate in the 23rd Annual Needham Virtual Healthcare Conference
CYTK

GlobeNewswire

4 months ago

Cytokinetics to Participate in the 23rd Annual Needham Virtual Healthcare Conference

Cytokinetics Announces Four Upcoming Presentations at the American College of Cardiology 73rd Annual Scientific Session
CYTK

GlobeNewswire

4 months ago

Cytokinetics Announces Four Upcoming Presentations at the American College of Cardiology 73rd Annual Scientific Session

2 Incredible Growth Stocks to Buy Right Now
CYTK

Motley Fool

4 months ago

2 Incredible Growth Stocks to Buy Right Now

30 Biggest Biotechnology Companies in the World
CYTK

Insider Monkey

4 months ago

30 Biggest Biotechnology Companies in the World

CYTK

Thomson Reuters StreetEvents

5 months ago

Q4 2023 CytomX Therapeutics Inc Earnings Call

Cytokinetics to Participate in March Investor Conferences
CYTK

GlobeNewswire

5 months ago

Cytokinetics to Participate in March Investor Conferences

Super Micro Computer and Deckers Outdoor Set to Join S&P 500; Others to Join S&P 100, S&P MidCap 400 and S&P SmallCap 600
CYTK

PR Newswire

5 months ago

Super Micro Computer and Deckers Outdoor Set to Join S&P 500; Others to Join S&P 100, S&P MidCap 400 and S&P SmallCap 600

Cytokinetics Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
CYTK

GlobeNewswire

5 months ago

Cytokinetics Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)

Cytokinetics Full Year 2023 Earnings: Misses Expectations
CYTK

Simply Wall St.

5 months ago

Cytokinetics Full Year 2023 Earnings: Misses Expectations

Share on Social Networks: